Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels

NCT06934200 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT06934200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06934200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Recruiting
Start date
May 19, 2025
Completion date
October 15, 2027
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

food hypersensitivity